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Heparin can substitute for double-stranded (ds) RNA in the autophosphorylation and activation of the interferon-inducible,
RNA-dependent eIF-2a protein kinase (PKR). We have used heparin oligosaccharides of defined lengths to examine the
heparin-mediated activation of human PKR. Heparin oligosaccharide with 8 sugar residues was nearly as efficient as 16-
residue heparin (Hep-16) in mediating the activation of PKR autophosphorylation, whereas 6-residue heparin was a poor
activator. When examined in combination, Hep-16 and dsRNA did not act synergistically in activating PKR autophosphoryla-
tion. The RNA-binding activity of recombinant PKR, measured with adenovirus VA RNA, was competed by poly(rI):poly(rC)
but not by Hep-16. When the catalytically inactive, histidine-tagged mutant PKR protein [His-PKR(K296R)] was examined as
a substrate for purified wild-type PKR, the intermolecular phosphorylation of His-PKR(K296R) was efficiently catalyzed by
dsRNA-activated PKR but not by heparin-activated PKR. However, eIF-2a phosphorylation was catalyzed by both heparin-
and dsRNA-activated PKR. Preincubation of PKR with Hep-16 in the absence of ATP blocked subsequent autophosphorylation
mediated either by Hep-16 or dsRNA, whereas preincubation with dsRNA either alone or in combination with Hep-16 did
not impair subsequent autophosphorylation. Neither Hep-16 nor dsRNA caused a detectable degradation of PKR during
preincubation or subsequent autophosphorylation of PKR. These results suggest that, while both dsRNA and heparin are
capable of activating PKR autophosphorylation, the structural and functional basis of PKR activation differs for these two
classes of polyanionic biomolecules. q 1996 Academic Press, Inc.
INTRODUCTION the best characterized of the PKR substrates, both in
structural and functional terms. PKR catalyzes the phos-
Among the enzymes induced by interferon (IFN)4 is phorylation of eIF-2a at serine residue 51 (Lasky et al.,
the RNA-dependent protein kinase (PKR) (Samuel, 1991). 1982; Pathak et al., 1988). Phosphorylation of eIF-2 leads
PKR is a central component of the IFN-induced antiviral to an inhibition of translation (Hershey, 1989; Samuel,
response (Lee and Esteban, 1993; Mathews, 1993; Meurs 1993; Clemens, 1996). A variety of physiologic conditions,
et al., 1992; Samuel, 1991). The PKR protein acquires including IFN treatment and virus infection (Samuel,
protein serine/threonine kinase activity following auto- 1991; Schneider and Shenk, 1987), cause the phosphory-
phosphorylation, a process mediated by RNA with dou- lation state of eIF-2a to increase and mRNA translation
ble-stranded character (Clemens, 1996; Samuel, 1993). to subsequently decrease.
Following activation, PKR catalyzes the intermolecular Several viruses encode RNAs that are bound by PKR
phosphorylation of at least three protein substrates: the and either activate or antagonize the autophosphoryla-
alpha subunit of protein synthesis initiation factor 2 (Sam- tion of PKR (Mathews, 1993; Samuel, 1993). The RNA-
uel, 1979); the PKR protein itself (Thomis and Samuel, binding domain of PKR has been localized by mutational
1993); and the transcription factor inhibitor I-kappa B (Ku- analysis to the N-terminal region of the kinase (Feng et
mar et al., 1994). Protein synthesis factor eIF-2 is so far al., 1992; Green and Mathews, 1992; Katze et al., 1991;
McCormack et al., 1992). Both activator and inhibitor
RNAs bind to the same PKR domain (McCormack et al.,1 Present address: Department of Cellular and Developmental Biol-
1992; McCormack and Samuel, 1995). The RNA-bindingogy, Harvard University, 16 Divinity Avenue, Cambridge, MA 02138.
domain of PKR includes a 20 amino acid core motif,2 Present address: Lombardi Cancer Center, Georgetown University
School of Medicine, Washington, DC 20007. designated R, that is conserved and often repeated in
3 To whom correspondence and reprint requests should be ad- dsRNA-binding proteins from both prokaryotic and eu-
dressed at Department of Molecular, Cellular and Developmental Biol- karyotic cells and their viruses (McCormack et al., 1992;
ogy, University of California, Santa Barbara, CA 93106. Fax: (805) 893-
St. Johnston et al., 1992). Curiously, in addition to certain4724.
natural and synthetic RNAs with double-stranded charac-4 Abbreviations used: IFN, interferon; PKR, IFN-inducible RNA-depen-
dent protein kinase; dsRNA, double-stranded RNA; Hep, heparin. ter, heparin has also been reported to activate PKR auto-
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phosphorylation (Hovanessian and Galabru, 1987; Patel al., 1985), except that the procedure was modified to
include a MonoQ ion-exchange fast liquid chromatogra-et al., 1994).
Heparin is a heterogeneously sized glycosaminogly- phy fractionation step. For production of the His-
PKR(K296R) protein, the cDNA encoding the full-lengthcan, consisting of repeating disaccharide subunits of
hexuronic acid and D-glucosamine with a high degree of PKR(K296R) was subcloned into pBlueBacHisC (In-
VitroGen) and a recombinant baculovirus was producedsulfation (Casu, 1985; Jackson et al., 1991). Heparin is
bound by a variety of different proteins and subsequently (Thomis and Samuel, 1993). The His-PKR(K296R) protein
was purified 45 hr after infection of Sf21 cells. Theaffects an array of physiologic processes. Among them
are growth factor-induced cell growth and differentiation washed cell pellet was resuspended in lysis buffer (20
mM HEPES, pH 7.5; 0.5 M KCl; 0.65% Nonidet P-40; 1modulated by heparin-binding polypeptide growth factors
(Ruoslahti and Yamaguchi, 1991) and thrombin-regulated mM PMSF, 10 mg/ml aprotinin; 2 mg/ml leupeptin), and
a 100,000 g supernatant fraction (S100) was prepared.hemostasis modulated by heparin-binding antithrombin
III (Hirsch, 1991). Although it has been described that His-PKR(K296R) was purified from the S100 by Ni2/-che-
lating Sepharose column chromatography (fast flowPKR binds to heparin-Sepharose and that commercially
obtained heparin of heterogeneous sulfation and size metal-chelating Sepharose, Pharmacia). The 100 mM im-
idazole eluate containing His-PKR(K296R) was dialyzedactivates PKR autophosphorylation (Hovanessian and
Galabru, 1987; Patel et al., 1994), little additional informa- against MonoS buffer (20 mM HEPES, pH 7.5; 0.1 mM
EDTA; 100 mM KCl; 0.01% Triton X-100; 10% glycerol; 5tion is available concerning the effect of heparin on PKR
activity. mM b-mercaptoethanol; 0.5 mM PMSF) and then further
fractionated by MonoS FPLC ion exchange chromatogra-As an extension of our studies on the structure and
function of the PKR kinase, we examined small heparin phy, using a linear salt gradient from 100 to 500 mM KCl
in MonoS buffer. MonoS fractions were dialyzed againstoligosaccharides of defined lengths for their ability to
activate PKR autophosphorylation and subsequent eIF- MonoQ buffer (20 mM HEPES, pH 7.5; 50 mM KCl; 2.5 mM
MgCl2 ; 2.5 mM MnCl2 ; 0.01% Triton X-100; 10% glycerol; 52a kinase activity. Comparison of results obtained for
purified human PKR and heparin with those obtained for mM b-mercaptoethanol; 0.5 mM PMSF).
PKR and dsRNA suggest unique structural and functional
PKR protein kinase assaybases of PKR interaction with these two classes of poly-
anionic biomolecules. [g-32P]ATP-mediated PKR autophosphorylation cata-
lyzed by PKR(Wt) was carried out in the absence of added
MATERIALS AND METHODS activator or in the presence of double-stranded RNA or
heparin, or both, as indicated. For measurement of theMaterials
eIF-2a kinase activity of PKR, 0.25 mg of purified eIF-2
was added to the standard reaction mixture. For mea-Heparin oligosaccharides of defined sizes and high
surement of the intermolecular phosphorylation of His-sulfate content were prepared by nitrous acid depolymer-
PKR(K296R), the purified His-PKR(K296R) substrate wasization of heparin and fractionation as described by Sud-
present at a twofold-molar excess over PKR(Wt). The 32P-halter et al. (1989); size homogeneity of the heparin oligo-
labeled polypeptide products were analyzed by SDS–saccharides was determined by high-performance gel
polyacrylamide gel electrophoresis and autoradiogra-permeation chromatography. Sulfur content was deter-
phy. Quantitation was by scanning autoradiograms thatmined by elemental analysis and was 11.7% for the hexa-
included internal dilution standards, using an LKB Ultros-saccharide, 12.6% for the octasaccharide, and 12.6% for
can XL laser densitometer. The procedures have beenthe hexadecasaccharide. Unfractionated heparin of 18-
described in detail (Samuel et al., 1986).to 25-residue average chain length was from Sigma.
Poly(rI):poly(rC) of 200-residue average chain length was
Western immunoblot analysisgenerously provided by the Antiviral Substances Pro-
gram, National Institute of Allergy and Infectious Dis- Western immunoblots were prepared as previously de-
eases, NIH. Purified eIF-2 was generously provided by scribed using antiserum prepared against recombinant
W. C. Merrick, Case Western Reserve University (Cleve- human PKR expressed in Escherichia coli (Thomis et al.,
land, OH). Other materials were as previously described 1992).
(Thomis and Samuel, 1993; McCormack et al., 1994).
Gel mobility-shift assay
Purification of PKR(Wt) and His-PKR(K296R)
The gel mobility-shift analysis was carried out follow-
ing the procedure of Gatignol et al. (1993) with the follow-The wild-type PKR enzyme was purified from ribosomal
salt-wash fractions prepared from IFN-treated human ing slight modifications (McCormack and Samuel, 1995).
The final reaction mixture (10 ml) contained 15 mM Tris–amnion U cells as previously described for the phosphor-
ylation of PKR(Wt) from mouse fibroblast cells (Berry et HCl, pH 7.8, 70 mM NaCl, 10 mM KCl, 1 mM EDTA, 6%
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(v/v) glycerol, 0.01% (v/v) Triton X-100, 25 ng ovalbumin,
2 units of RNasin (Promega), 10 ng yeast RNA (5*–3*
oligonucleotides), recombinant PKR (5 ng protein), and
32P-labeled adenovirus VAI probe (2.3 nM ) as indicated.
Incubation was for 20 min at room temperature before
loading onto a 10% native acrylamide gel (80:1 acryl-
amide:bisacrylamide) made in 0.5X Tris-borate-EDTA
buffer. Gels were prerun at 47 for 1 hr at 200 V before
addition of the sample; electrophoresis was then at 280
V for 5 hr or until the xylene cyanol was approximately
3 cm from the bottom of the gel. The gels were then
dried and subjected to autoradiography. In competition
experiments the competitor, either poly(rI):poly(rC) or
heparin-16, was added at the same time as the 32P-la-
beled adenovirus VAI probe.
RESULTS
Minimum-size requirement of heparin for PKR
activation
FIG. 2. Activation of PKR(Wt) kinase by either heparin or double-
stranded RNA leads to eIF-2a phosphorylation. [g-32P]ATP-mediatedPKR(Wt) purified from IFN-treated cells is dependent
autophosphorylation of the a subunit of protein synthesis initiationupon dsRNA for activation of autophosphorylation, a well-
factor eIF-2 catalyzed by purified PKR was measured as describedestablished observation (Clemens, 1996; Samuel, 1993).
under Materials and Methods. The standard reaction mixture contained
For the PKR(Wt) used in this study, which was purified dsRNA (poly(rI):poly(rC), 0.5 mg/ml), heparin (Hep-16, 1.0 mg/ml), and
from human U cells, readily detectable autophosphoryla- eIF-2 (0.25 mg) as indicated. The autoradiogram is of the complete gel
area. PKR, position of the autophosphorylated protein PKR; a, positiontion was obtained with 0.01 mg/ml poly(rI):poly(rC) and
of the alpha subunit of eIF-2.saturated by 0.1 mg/ml (data not shown, Fig. 4). Confirm-
ing the original finding of Hovanessian and Galabru
(1987), commercially available heparin likewise activated concentration dependence between 0.1 and 1.0 mg/ml
PKR autophosphorylation, displaying a relatively sharp (data not shown).
Commercially available heparin is a heterogeneously
sized and sulfated polymer, typically ranging from Mr
5,000 to 30,000 (Casu, 1985). To define the minimal struc-
tural requirements of heparin required to activate PKR,
heparin oligosaccharides of defined sizes and high sul-
fate content were prepared by nitrous acid depolymeriza-
tion of commercially obtained heparin. These small hepa-
rin oligosaccharides were tested for their ability to acti-
vate purified PKR autophosphorylation (Fig. 1). Heparin
hexasaccharide (Hep-6) was a poor PKR activator (Fig.
1, lanes b–g), whereas the heparin hexadecasaccharide
(Hep-16) was an efficient activator of PKR autophosphor-
ylation (Fig. 1, lanes n–r). Heparin octasaccharide (Hep-
8) likewise activated PKR autophosphorylation to a com-
parable extent as Hep-16, but higher concentrations
were required of Hep-8 (Fig. 1). As shown in Fig. 2, PKR
activated by Hep-16 was able to catalyze the phosphory-
lation of the alpha subunit of eIF-2 (lane d), a well-estab-
FIG. 1. Activation of PKR autophosphorylation by heparin and double- lished property of PKR activated by dsRNA (Clemens,
stranded RNA. [g-32P]ATP-mediated autophosphorylation of purified
1996; Samuel, 1993).PKR was measured as described under Materials and Methods. The
standard reaction mixture contained homogeneously sized heparin oli-
Intra- and intermolecular autophosphorylation of PKRgosaccharide at the indicated concentration (mg/ml) as follows: heparin
hexasaccharide (Hep-6, lanes b-g); octasaccharide (Hep-8, lanes h-m);
Two models have been proposed for the activation ofhexadecasaccharide (Hep-16, lanes n-r); or, no heparin added (lane a).
The autoradiogram is of the complete gel area. PKR; one postulates that intramolecular autophosphory-
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mixtures that contained His-PKR(K296R) (Fig. 3, lanes
8 and 9). As controls, when the catalytic-deficient His-
PKR(K296R) mutant protein was examined alone, it was
not phosphorylated either in the absence or presence of
added dsRNA (Fig. 3, lanes 4 and 5) as previously re-
ported (Thomis and Samuel, 1993) or in the presence of
heparin (lane 6). Also, consistent with the results ob-
tained earlier in Fig. 1, when the PKR(Wt) protein was
examined alone, both Hep-16 and dsRNA activated auto-
phosphorylation (Fig. 3, lanes 2 and 3), but PKR(Wt)
lacked kinase activity in the absence of added activator
(Fig. 3, lane 1).
Heparin and dsRNA act independently of each other
in the activation of PKR
As an approach to assess the mechanism of activation
of PKR autophosphorylation by heparin as compared to
FIG. 3. Intermolecular phosphorylation of His-PKR(K296R) substrate
dsRNA, and whether the two classes of anionic activatorsby PKR(Wt) kinase is double-stranded RNA-dependent. In vitro phos-
can act synergistically, heparin and dsRNA were exam-phorylation reaction mixtures contained no activator (lanes 1, 4, and
7); 0.1 mg/ml poly[rI]:poly[rC] (ds, lanes 2, 5, and 8); or 2.0 mg/ml heparin ined alone and in combination with each other (Fig. 4).
as Hep-16 (H, lanes 3, 6, and 9). Lanes 1–3 contained PKR(Wt), lanes Hep-16, at a low concentration (0.1 mg/ml) that activated
4–6 contained a molar amount of His-PKR(K296R) similar to the amount autophosphorylation of PKR only to a marginally detect-
of PKR(Wt) in lanes 1–3, and lanes 7–9 contained equimolar amounts
able extent (Fig. 1B, lane o, and Fig. 4, lane n), did notof PKR(Wt) and His-PKR(K296R) (Wt / K296R). Reaction mixtures were
significantly affect the concentration of dsRNA requiredincubated at 307 for 5 min; 32P-labeled phosphoproteins were fraction-
ated on a SDS–PAGE (10% polyacrylamide) gel and visualized by auto- to activate autophosphorylation (Fig. 4, lanes a–d com-
radiography. The positions of the 67-kDa PKR(Wt) and 71-kDa His- pared to lanes e–h). Interestingly, a concentration of
PKR(K296R) protein bands are indicated. Hep-16 saturating for activation of autophosphorylation,
10 mg/ml (Fig. 1B, lane r and Fig. 4, lane p), yielded a
lower level of phosphorylation than did a saturating level
lation is involved in the activation of PKR (Berry et al., of dsRNA but did not adversely affect the enhanced phos-
1985; Galabru et al., 1989), whereas the other proposes phorylation observed with dsRNA (Fig. 4, lanes a–d com-
the involvement of intermolecular PKR phosphorylation pared to lanes i–l).
(Kostura and Mathews, 1989). Recent studies definitively The RNA-binding site of PKR has been localized to a
established that autophosphorylation of PKR may indeed novel R motif within the N-terminal region of the protein,
include intermolecular phosphorylation events, because a motif now recognized as part of numerous cellular and
the histidine-tagged PKR(K296R) mutant is a substrate for viral dsRNA-binding proteins (St. Johnston et al., 1992;
PKR(Wt) kinase activated by dsRNA (Thomis and Samuel, McCormack et al., 1992; Samuel, 1993). Purified recombi-
1993). The K296R mutation, which substitutes an arginine nant PKR mutant K296R(1–551) efficiently bound 32P-la-
for lysine at position 296 of kinase catalytic subdomain beled adenovirus VA RNA, both by Northwestern analysis
II of PKR, destroys PKR kinase activity (Katze et al., 1991;
Thomis and Samuel, 1992). The engineered N-terminal
histidine tag adds about 4 kDa to the size of PKR(K296R)
and thus allows electrophoretic separation of PKR(Wt)
and His-PKR(K296R) from each other (Thomis and Sam-
uel, 1993).
As shown in Fig. 3, efficient intermolecular phosphory-
lation of His-PKR(K296R) in trans by PKR(Wt) was ob-
served in the presence of dsRNA (Fig. 3, lane 8), but was
completely absent in the absence of activator RNA (Fig. 3,
lane 7). Surprisingly, when heparin was used to activate
PKR(Wt), the intermolecular phosphorylation of His- FIG. 4. Activation of PKR autophosphorylation by heparin and double-
stranded RNA, either alone or in combination with each other.PKR(K296R) was marginally detectable (Fig. 3, lane 9)
[g-32P]ATP-mediated autophosphorylation of purified PKR was mea-compared to when dsRNA was used as the activator (Fig.
sured as described under Materials and Methods. The standard reac-
3, lane 8). However, the intramolecular phosphorylation tion mixture contained dsRNA and/or heparin at the indicated concen-
of PKR(Wt) was readily detected, both with Hep-16 (lane trations (mg/ml). The region of the autoradiogram corresponding to the
67-kDa 32P-labeled PKR is shown.9) and with dsRNA (lane 8) as the activator, in the reaction
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added to the reaction mixture (Fig. 6A, lane C), consistent
with the prior observation that dsRNA is required for the
binding of ATP to PKR (Bischoff and Samuel, 1985; Gala-
bru and Hovanessian, 1987) and the finding described
herein that dsRNA and Hep-16 in combination activated
PKR autophosphorylation (Fig. 5). By contrast, preincuba-
tion of PKR with 1 mg/ml of Hep-16 for 20 min at 307 in
the absence of ATP surprisingly prevented subsequent
autophosphorylation when [g-32P]ATP and dsRNA were
added to the reaction mixture (Fig. 6A, lane d). Preincuba-
tion on ice under the same conditions had no adverse
effect (data not shown).
FIG. 5. Electrophoretic mobility-shift competition analysis of PKR RNA
binding activity. Gel mobility shift assays were carried out as described
under Materials and Methods, with constant concentrations of human
PKR protein and adenovirus VAI RNA probe and competitor as indi-
cated. Lane a, probe alone; lanes b and g, no competitor; lane c, Hep-
16 at 1 mg/ml, lane d, Hep-16 at 10 mg/ml, lane e, poly(rI):poly(rC) at
0.1 mg/ml; and lane f, poly(rI):poly(rC) at 1 mg/ml.
as previously reported (McCormack et al., 1994) and by
gel mobility-shift analysis as shown in Fig. 5 (lanes b
and g). The binding of VA RNA was effectively competed
by dsRNA (lanes e and f), but not by heparin (lanes c and
d), suggesting that the two activators bind to independent
sites on PKR (Fig. 5). Hovanessian and Galabru (1987)
originally showed that natural PKR(Wt) protein binds to
heparin-Sepharose. This binding to heparin is indepen-
dent of a functional dsRNA-binding activity, because the
full-length recombinant PKR proteins PKR(K64E),
FIG. 6. Effect of preincubation on activation of PKR autophosphoryla-
PKR(K296R), and PKR(Wt) expressed in COS cells tion by heparin and double-stranded RNA. (A) Purified PKR was preincu-
(McCormack et al., 1994) all bound to heparin-agarose bated (/) or not (0) for 20 min at 307 under standard conditions, except
no ATP was present and either Hep-16 (1 mg/ml) or poly(rI):poly(rC)(data not shown).
(0.5 mg/ml) was added as indicated. Following preincubation, 100 mM
ATP containing [g-32P]ATP and dsRNA were added and the standardPreincubation with heparin impairs PKR activation
reaction mixture was incubated for an additional 20 min at 307 before
analysis. (B) Preincubation was as for (A), except Hep-16 at the indi-Activation of PKR enzymic function by dsRNA-binding
cated concentration (mg/ml) or dsRNA at 0.5 mg/ml was present. Follow-at the N-terminal region of the protein presumably results
ing preincubation, 100 mM ATP containing [g-32P]ATP and either dsRNAfrom an RNA-mediated conformational change affecting
(0.5 mg/ml) or Hep-16 at the indicated concentration was added and
the C-terminal kinase catalytic subdomains, because the standard reaction was incubated for an additional 20 min at 307
ATP can be bound by PKR only in the presence of dsRNA before analysis. (C) Preincubation was as for (A), except Hep-16 (1
mg/ml) and ATP (100 mM unlabeled) were present as indicated andactivator (Bischoff and Samuel, 1985; Galabru and Ho-
preincubation was at 307 for the specified period of time. Followingvanessian, 1987). Because of these earlier observations
preincubation, [g-32P]ATP and dsRNA (0.5 mg/ml) were added and theobtained with dsRNA, the effect of preincubation with
standard reaction was incubated for an additional 20 min at 307 before
heparin was also examined. Preincubation of PKR with analysis. For (A), the autoradiogram is of the complete gel area; for (B)
dsRNA in the absence of ATP did not impair subsequent and (C) the autoradiograms correspond to the region of the 67-kDa
32P-labeled PKR protein.autophosphorylation when [g-32P]ATP and Hep-16 were
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with [32P]ATP (Fig. 7A) consistent with the results shown
in Fig. 6, parallel reactions carried out with unlabeled
ATP and then analyzed by Western immunoblot analysis
did not reveal detectable degradation of PKR (Fig. 7B).
The slightly retarded mobility of PKR observed in lane b*
of the Western blot (Fig. 7B) corresponds to the autophos-
phorylated form of PKR (Fig. 7A, lane b); it is well-estab-
lished that the phosphorylated form of PKR often displays
a retarded mobility on SDS–PAGE as compared to the
unphosphorylated form of PKR (Lasky et al., 1982; Thomis
and Samuel, 1993).
DISCUSSION
Several important points emerge from the results re-
ported herein concerning the activation of PKR auto-
phosphorylation by heparin. First, the results not only
confirm that heterogeneously sized heparin activates
PKR autophosphorylation but they further demonstrate
the minimum size requirement for activation of PKR au-
tophosphorylation using homogeneously sized heparin
oligosaccharides. Second, heparin-activated PKR(Wt)FIG. 7. Effect of preincubation with heparin on activation of PKR
catalyzes the phosphorylation of eIF-2a as does dsRNA-autophosphorylation and stability of PKR. Preincubation was as de-
scribed in the legend of Fig. 6A, except that the mixture contained Hep- activated PKR, whereas only dsRNA-activated PKR(Wt)
16 (1 mg/ml) as indicated. Following preincubation, dsRNA (0.5 mg/ml) and not heparin-activated PKR(Wt) catalyzes the inter-
and ATP, either [g-32P]ATP (A) or unlabeled ATP (B) were added as molecular phosphorylation of His-PKR(K296R). Third,
indicated. The standard reaction mixtures were then incubated for an
the structural and functional basis of PKR interactionadditional 20 min at 307 before analysis. (A) The 32P-labeled samples
with heparin differs from that of dsRNA as revealed fromwere analyzed for [g-32P]ATP-mediated autophosphorylation of PKR.
(B) The unlabeled samples were analyzed for PKR protein by Western competition RNA binding data and from the effects of
immunoblot using 125I-protein A as described under Materials and preincubation with the polymers in the absence of ATP
Methods. The autoradiograms are of the complete gel areas. on subsequent PKR autophosphorylation activation.
Fourth, neither heparin nor dsRNA when incubated with
purified PKR mediates a detectable degradation of PKR.The concentration of Hep-16 required during preincu-
The minimum saccharide size of heparin required tobation to mediate the subsequent impairment of auto-
efficiently activate PKR autophosphorylation was the hep-phosphorylation in the presence of dsRNA was between
arin octasaccharide. The heparin hexasaccharide was a0.1 and 1.0 mg/ml (Fig. 6B, lanes a–d), similar to the
very poor activator of PKR autophosphorylation. Theseconcentration of Hep-16 required for activation of PKR
results obtained for PKR are comparable to those re-autophosphorylation (Fig. 1B). But preincubation of PKR
ported for basic fibroblast growth factor-mediated bio-with dsRNA did not impair subsequent autophosphoryla-
chemical and biological activities (Ishihara et al., 1993;tion in the presence of Hep-16, even when examined at
Ornitz et al., 1992). For example, heparin oligosaccharide10 mg/ml Hep-16 (Fig. 6B, lanes e–h). Inhibition of PKR
with as few as 8 to 10 sugar residues was sufficient toautophosphorylation by preincubation at 307 with Hep-
mediate bFGF-receptor binding and induce mitogenesis.16 was rapid in the absence of ATP (Fig. 6C, lanes d –
Heparin, although able to mediate the autophosphory-f). However, the presence of 100 mM ATP during the
lation of PKR(Wt) and the intermolecular phosphorylationpreincubation with Hep-16 completely prevented the inhi-
of eIF-2a, could not mediate the intermolecular trans-bition (Fig. 6C, lanes g and h).
phosphorylation of His-PKR(K296R). The finding that hep-
arin-activated PKR(Wt) could not catalyze the intermolec-PKR remains intact during preincubation and
ular phosphorylation of His-PKR(K296R) in the mannersubsequent autophosphorylation
observed for dsRNA-activated PKR(Wt) was unexpected
(Thomis and Samuel, 1993, 1995). This result suggestsWe considered the possibility that preincubation with
Hep-16 led to degradation of PKR and thus loss of auto- that the intermolecular phosphorylation of His-PKR
(K296R) may require the binding of either the PKR(Wt)phosphorylation activity. However, the results shown in
Fig. 7 suggest that this is unlikely. Although preincuba- enzyme or the His-PKR(K296R) substrate, or both, to RNA
in order for subsequent intermolecular phosphorylationtion with Hep-16 in the absence of ATP impaired subse-
quent dsRNA-dependent autophosphorylation measured to occur. Alternatively, the conformational change of PKR
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associated with dsRNA-binding (Bischoff and Samuel, gion which are essential for the dsRNA-binding activity
of PKR (Green et al., 1995; McCormack et al., 1994;1985) may facilitate the intermolecular phosphorylation.
Because RNA molecules too small to accommodate two McMillan et al., 1995). So far, attempts to generate PKR
deletion mutants that are activated by dsRNA but not byPKR molecules can mediate the activation of PKR (Man-
che et al., 1992), the intermolecular autophosphorylation heparin have been unsuccessful.
The molecular basis of the inhibition of PKR autophos-of PKR may occur by a mechanism that is not dependent
upon the physical bridging of two PKR molecules by RNA, phorylation when purified PKR was preincubated with
Hep-16 in the absence of ATP, but not in the presencebut rather is dependent upon PKR protein–protein inter-
action. Our results further suggest that PKR protein–pro- of ATP, is unclear. A possible explanation is that preincu-
bation of PKR and Hep-16 in the absence of ATP leadstein interaction is not sufficient for intermolecular phos-
phorylation events to occur. Combined biochemical and to a conformational change of PKR that precludes the
subsequent binding of ATP by PKR, either in the presencegenetic evidence has established that PKR undergoes
intermolecular association with itself, both in vitro and in or absence of dsRNA. Because proteolysis mediated by
phosphorylation can be an important regulatory mecha-vivo (Langland and Jacobs, 1992; Cosentino et al., 1995;
Patel et al., 1995; Ortega et al., 1996). In some cases, nism of gene expression as exemplified by the process
of NF-kB activation (Thanos and Maniatis, 1995), we ex-RNA-binding was neither necessary nor sufficient for PKR
multimerization (Patel et al., 1995; Ortega et al., 1996), amined the possibility that PKR undergoes proteolytic
degradation during preincubation with heparin. However,and dimerization was neither sufficient nor essential for
activation (Wu and Kaufman, 1996). this does not seem likely because Western immunoblot
analysis revealed the expected size of about 67-kDa byThe structural basis of heparin binding to PKR is not
known. Our finding that Hep-16 did not compete the bind- SDS–PAGE for PKR, either preincubated or not, with ei-
ther Hep-16 or dsRNA.ing of adenovirus VA RNA by PKR in the gel mobility shift
assay, whereas poly(rI):poly(rC) did compete, suggests The underlying mechanism of cell growth regulation
by heparin is not well understood, but may include inthat heparin and RNA likely bind to different sites on the
PKR protein or that VA RNA has a substantially higher part the functional modulation of various heparin-binding
growth factors (Ruoslahti and Yamaguchi, 1991). Inter-binding affinity for PKR than does heparin. The former
explanation appears most likely, because PKR(K64E) mu- feron is also a regulator of cell growth and differentiation,
and the PKR kinase is implicated in the regulation oftant protein bound to heparin-agarose and this mutation
is known to destroy RNA-binding activity (McCormack et these cellular activities and may function as a tumor
suppressor (Lengyel, 1993; Samuel, 1993). Although noal., 1994). The RNA binding site on PKR has been local-
ized to a novel 20 residue motif R within the N-terminal evidence of tumor suppressor activity of PKR was ob-
served in mice devoid of a functional PKR gene (Yang ethalf of the PKR protein (Mathews, 1993; McCormack et
al., 1992; Samuel, 1993; St. Johnston et al., 1992). Many al., 1995), expression of functionally defective PKR pro-
tein in mouse 3T3 cells causes malignant transformationproteins are known to bind heparin, and a comparative
analysis of structurally defined heparin binding se- and 3T3 cells overexpressing either inactive PKR (Koro-
milas et al., 1992; Meurs et al., 1993) or an inhibitor ofquences has revealed a distinct spatial distribution of
basic residues (Margalit et al., 1993). When heparin bind- PKR (Barber et al., 1994) are highly tumorigenic when
injected into nude mice. Conceivably a physiologic roleing sequences fold into either an a-helix or a b-strand
fold, the alignment of two basic residues was conserved for heparin activation of PKR, if one exists, may relate to
the control of cell growth and differentiation via activationat the extremes of each of the structures, but with differ-
ent linear separations (Margalit et al., 1993). The amino of PKR, just as RNA activation of PKR is implicated in the
control of virus replication in IFN-treated cells (Mathews,acid sequence of PKR deduced from the human cDNA
sequence (Thomis et al., 1992) includes within the C- 1993; Samuel, 1991).
terminal half of the PKR protein the proposed heparin
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